Medicine
Aplisol 5 IU/0.1 mL injection
Aplisol 5 IU/0.1 mL injection is a prescription medicine containing Tuberculin purified protein derivative for intradermal use, marketed by A-S Medication Solutions, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Tuberculin purified protein derivative
- Brand
- Aplisol
- Strength
- 5 IU/0.1 mL
- Dosage form
- Injection
- Route
- Intradermal
- Packs
- 1 vial
- Marketing authorisation holder
- A-S Medication Solutions
- Manufacturer
- A-S Medication Solutions
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 April 2008
- Identifiers
- RxCUI 313532, 798408DailyMed set ID 9f025046-850f-46c1-bdfd-245032144307NDC 50090-1336Application BLA103782
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 1 mL in 1 vial | 50090-1336-0 | A-S Medication Solutions | 28 November 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Tuberculin purified protein derivative 5 IU/0.1 mL injection.
Clinical summary
Tuberculin purified protein derivative is a skin test antigen indicated to aid diagnosis of tuberculosis infection (TB) in persons at increased risk of developing active disease. It is available as injection for intradermal use. MedsAcross supplies Tuberculin purified protein derivative for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Tuberculin purified protein derivativeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TUBERSOL prescribing information (Sanofi Vaccines) · U.S. National Library of Medicine, DailyMed
Need Aplisol 5 IU/0.1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.